Lodixem solution for injection 50 mg/ml ampoule 2 ml No. 10

Lodixem injection solution is indicated for:

Composition

Active ingredient: ethylmethylhydroxypyridine succinate;

1 ml of ethyl methylhydroxypyridine succinate 50.0 mg;

Excipients: sodium metabisulfite (E 223), water for injections.

Contraindication

Acute hepatic or renal failure, hypersensitivity to the drug, childhood, pregnancy, breastfeeding.

Method of application

The drug is administered intramuscularly or intravenously (jet, drip). Doses are selected individually. When administered by infusion, the drug should be diluted in saline (200 ml). Treatment of adults begins with a dose of 50-100 mg 1-3 times a day, gradually increasing the dose until a therapeutic effect is obtained. The drug is administered slowly by jet over 5-7 minutes, drip - at a rate of 40-60 drops per minute. The maximum daily dose should not exceed 800 mg.

Application features

Pregnant women

Contraindicated.

Children

Not applicable.

Drivers

During treatment, caution should be exercised when driving or operating machinery, given the likelihood of side effects that may affect reaction speed and ability to concentrate.

Overdose

Overdose may cause drowsiness. Treatment is detoxification therapy.

Side effects

Rarely - nausea, dry mouth, allergic reactions, drowsiness, sleep disturbance, anxiety, emotional reactivity, distal hyperhidrosis, headaches, coordination disorders, increased blood pressure, decreased blood pressure.

Interaction

The drug enhances the effect of benzodiazepine anxiolytics, anticonvulsants (carbamazepine), antiparkinsonian drugs (levodopa). Reduces the toxic effect of ethyl alcohol.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Shelf life - 2 years.